Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Entrate totali | $1.4B | $1.3B | $693M | $532M | $321M | $258M | $188M | $62M |
| Utile lordo | $1.0B | $886M | $381M | $286M | $130M | $84M | $29M | $16M |
| Margine lordo% | 69.9% | 69.6% | 55.0% | 53.8% | 40.6% | 32.4% | 15.3% | 25.9% |
| Risultato Operativo (EBIT) | ($261M) | ($239M) | ($691M) | ($196M) | ($265M) | ($244M) | ($193M) | ($120M) |
| Margine operativo % | -18.2% | -18.8% | -99.7% | -36.9% | -82.8% | -94.5% | -102.9% | -193.0% |
| Reddito netto | ($254M) | ($245M) | ($706M) | ($214M) | ($290M) | ($259M) | ($210M) | ($115M) |
| Margine netto% | -17.8% | -19.3% | -101.8% | -40.3% | -90.4% | -100.5% | -111.6% | -185.2% |
| EBITDA | — | ($222M) | ($610M) | ($133M) | ($237M) | ($220M) | ($169M) | ($100M) |
| Utile per azione (EPS) | $-1.44 | $-1.41 | $-4.35 | $-1.39 | $-1.71 | $-1.53 | $-1.24 | $-0.72 |
| Azioni in circolazione (M) | — | 174M | 162M | 154M | 170M | 170M | 170M | 161M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di TEM. /companies/us/TEM
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms